Development of a revised plant synthetic biology toolkit to advance crop improvement

Informazioni relative al progetto

REPLANT

ID dell’accordo di sovvenzione: 101060616

DOI

10.3030/101060616

Progetto concluso il 31 Dicembre 2022

Data della firma CE 17 Maggio 2022

Data di avvio 1 Giugno 2022

Data di completamento 30 Novembre 2024

Finanziato da

Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 206 641,20

Coordinato da

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Spain

Periodic Reporting for period 1 - REPLANT (Development of a revised plant synthetic biology toolkit to advance crop improvement)

Periodo di rendicontazione: 2022-06-01 al 2024-11-30

The aim of REPLANT was to generate a new plant SynBio toolkit based on the Phytobrick architecture that included the latest developments in protein production and gene editing techniques (Work Package 1). The advantages provided by the REPLANT were going to be demonstrated by two proof-of-concept experiments with biotechnological applications (Work Package 2): enhancing the production of SARS-CoV2 recombinant antibodies in plant leaves, and modification of tomato plant architecture in variants of commercial interest. This toolkit, alongside its dissemination approaches would allow a faster advancement of plant SynBio, accelerating the development of improved crops to help solve the global challenges of sustainability and food security.
REPLANT was planned as a two-year project with a six-month secondment in the multinational seed company Semillas Fitó. However, REPLANT was terminated after seven months because Eduardo González Grandío obtained a Ramón y Cajal Contract from the Spanish State Agency for Research that was not compatible with the MSCA Postdoctoral fellowship.

Periodic Reporting for period 1 - REPLANT (Development of a revised plant synthetic biology toolkit to advance crop improvement)

Scarica Scarica il contenuto della pagina